A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)

PHASE3CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

August 31, 1998

Study Completion Date

December 31, 2004

Conditions

Adult T-cell LeukemiaLymphoma

Interventions

DRUG

VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis

DRUG

biweekly-CHOP with G-CSF and intrathecal prophylaxis

Trial Locations (1)

Nagasaki University Graduate School of Biomedical Science, Nagasaki

All Listed Sponsors

collaborator

Ministry of Health, Labour and Welfare, Japan

OTHER_GOV

lead

Japan Clinical Oncology Group

OTHER

NCT00145002 - A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) | Biotech Hunter | Biotech Hunter